Characteristics of providers_
| Variables | Description | N (number of practices) | % |
|---|---|---|---|
| Practice location | Urban | 49 | 70.0 |
| Rural | 21 | 30.0 | |
| Type of practice | Public | 60 | 85.7 |
| Private | 10 | 14.3 | |
| Electronic exchange of patient information | Yes | 38 | 54.3 |
| No | 32 | 45.7 | |
| Review of indicators of patient care | Yes | 44 | 62.9 |
| No | 26 | 37.1 | |
| Routine development of patient care plans for groups of patients | Yes | 37 | 53.6 |
| No | 33 | 46.4 |
Logistic regression analysis of predictors of adverse events_
| Predictor | B (SE) | Wald χ2 | p-value | OR | 95% CI |
|---|---|---|---|---|---|
| Number of medications / Polypharmacy | -0.28 (0.34) | 0.69 | 0.492 | 0.75 | 0.34-1.62 |
| Medication review | -0.27 (0.30) | 0.83 | 0.406 | 0.76 | 0.42-1.36 |
| Repetition of information | 0.42 (0.17) | 6.13 | < 0.001 | 1.53 | 1.20-1.95 |
| Encouragement to express concerns | 0.76 (0.47) | 2.65 | 0.008 | 2.14 | 1.14-4.03 |
| Transport barriers | 0.32 (0.21) | 2.26 | 0.024 | 1.1 | 1.02-1.95 |
| Cost barriers | -0.07 (0.05) | 1.66 | 0.097 | 0.93 | 0.86-1.99 |
Spearman’s rank correlations between patient safety indicators_
| Variable | Repetition | Adverse events | Encouragement | Transport barriers | Cost barriers |
|---|---|---|---|---|---|
| Repetition | 1.00 | 0.16 | -0.05 | 0.09 | 0.11 |
| Adverse events | 0.16 | 1.00 | -0.08 | 0.12 | 0.15 |
| Encouragement | -0.05 | -0.08 | 1.0 | -0.04 | -0.03 |
| Transport barriers | 0.09 | 0.12 | -0.04 | 1.00 | 0.22 |
| Cost barriers | 0.11 | 0.15 | -0.03 | 0.22 | 1.00 |
Characteristics of patients_
| Variables | N (number of practices) | % |
|---|---|---|
| Sex | ||
| Female | 1268 | 62.7 |
| Male | 754 | 37.3 |
| Age (years) categories | ||
| 45–54 | 505 | 23.7 |
| 55–74 | 1355 | 63.6 |
| 75 + | 271 | 12.7 |
| Higher education | ||
| Yes | 1247 | 61.7 |
| No | 774 | 38.3 |
| Employment | ||
| Yes | 886 | 43.9 |
| No | 1133 | 56.1 |
| Income | ||
| Low | 758 | 43.1 |
| Medium | 597 | 34.0 |
| High | 403 | 22.9 |
| Living place | ||
| Urban | 1094 | 54.2 |
| Rural | 923 | 45.8 |
| Living with other people | ||
| Yes | 1402 | 73.1 |
| No | 515 | 26.9 |
Cross-tabulation of polypharmacy and medication review, NA – not applicable_
| Number of medications | Medication review: Yes (N, %) | Medication review: No (N, %) | Not sure (N, %) | Total (N) |
|---|---|---|---|---|
| No medication | NA | NA | NA | 282 |
| 1-2 | 277 (31.2%) | 554 (62.2%) | 56 (6.6%) | 890 |
| 3-4 | 240 (39.9%) | 306 (50.8%) | 54 (9.0%) | 602 |
| 5-9 | 119 (46.3%) | 120 (46.7%) | 18 (7.0%) | 257 |
| ≥ 10 | 14 (43.8%) | 11 (34.4%) | 7 (21.9%) | 33 |
| Total | 650 (36.6%) | 991 (55.8%) | 135 (7.6%) | 1776 |
Distribution of responses to patient safety indicators_
| Indicator | Category | N (number of practices) | % |
|---|---|---|---|
| Number of medications regularly taken | Does not take any medicine | 282 | 8.5 |
| 1-2 | 890 | 27.0 | |
| 3-4 | 602 | 18.2 | |
| 5-9 | 257 | 7.8 | |
| 10 or more | 33 | 1.0 | |
| Medication review in the last 12 months | Yes | 650 | 19.7 |
| No | 991 | 30.0 | |
| I’m not sure | 135 | 4.1 | |
| Repetition of medical information | Yes, definitely | 155 | 4.7 |
| Yes, to some extent | 246 | 7.4 | |
| Neither | 849 | 25.7 | |
| Not at all | 1439 | 43.6 | |
| I’m not sure | 295 | 8.9 | |
| Frequency of adverse events | Always | 22 | 0.7 |
| Often | 157 | 4.8 | |
| Sometimes | 380 | 11.5 | |
| Rarely | 721 | 21.8 | |
| Never | 1596 | 48.3 | |
| Not applicable | 101 | 3.1 | |
| Encouragement to express concerns | Always | 7 | 0.2 |
| Often | 95 | 2.9 | |
| Sometimes | 299 | 9.1 | |
| Rarely | 457 | 13.8 | |
| Never | 1967 | 59.6 | |
| Not applicable | 147 | 4.5 | |
| Foregoing care due to transport difficulties | Always | 3 | 0.1 |
| Often | 33 | 1.0 | |
| Sometimes | 103 | 3.1 | |
| Rarely | 230 | 7.0 | |
| Never | 1695 | 75.9 | |
| Not applicable | 96 | 2.9 | |
| Foregoing care due to medical costs | Always | 91 | 2.8 |
| Often | 123 | 3.7 | |
| Sometimes | 313 | 9.5 | |
| Rarely | 400 | 12.1 | |
| Never | 1700 | 51.5 | |
| Not applicable | 337 | 10.1 |
